Fingerprint
Dive into the research topics of 'Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase II Study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase II Study
Caroline A. Nebhan, Douglas B. Johnson, Ryan J. Sullivan, Roda N. Amaria, Keith T. Flaherty, Jeffrey A. Sosman, Michael A. Davies
Research output: Contribution to journal › Article › peer-review
17
Scopus
citations